Back to UBS Group AG UBS Group AG

CYCNCYCN
Showing 8 of 13 quarters

Position history for UBS Group AGUBS Group AG's holdings in CYCLERION THERAPEUTICS INC

UBS Group AG holds 3,135 shares of CYCN (CYCLERION THERAPEUTICS INC), worth $10,627 as of 2026-Q2. The position was decreased (-7.5% shares).

Current Value

$10,627

Current Shares

3,135

Total Value Change

+$10,251

Total Shares Change

+2,990

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3,135
-7.5%
$10,6270.0%$3.39
0
2026-Q1
Increased
3,391
+801.9%
$5,2560.0%$1.35
17
2025-Q4
Increased
376
+667.4%
$4780.0%$1.18
12
2025-Q3
Decreased
49
-99.5%
$1130.0%$2.34
0
2025-Q2
Decreased
9,727
-25.2%
$28,3060.0%$3.00
0
2025-Q1
Increased
13,001
+34.5%
$32,5030.0%$2.57
17
2024-Q4
Increased
9,667
+6566.9%
$31,1280.0%$3.45
22
2024-Q3
Decreased
145
-94.6%
$3760.0%$2.62
0

Other major holders of CYCN: FMR LLC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used